GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearside Biomedical Inc (FRA:CLM) » Definitions » 5-Year Yield-on-Cost %

Clearside Biomedical (FRA:CLM) 5-Year Yield-on-Cost % : 0.00 (As of May. 18, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Clearside Biomedical 5-Year Yield-on-Cost %?

Clearside Biomedical's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Clearside Biomedical's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:CLM's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.64
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Clearside Biomedical's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Clearside Biomedical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearside Biomedical's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearside Biomedical's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Clearside Biomedical's 5-Year Yield-on-Cost % falls into.



Clearside Biomedical 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Clearside Biomedical is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Clearside Biomedical  (FRA:CLM) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Clearside Biomedical 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Clearside Biomedical's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearside Biomedical (FRA:CLM) Business Description

Traded in Other Exchanges
Address
900 North Point Parkway, Suite 200, Alpharetta, GA, USA, 30005
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Clearside Biomedical (FRA:CLM) Headlines